«
»

Top

US OKs drug for postpartum depression

Apr 18, 2019

Prior to the approval of this medication, women diagnosed with postpartum depression were commonly treated with traditional anti-depressants; however, now this marks the first medication designed specifically for postpartum depression.

According to US media, the estimated treatment will cost $34,000 a year for people without health insurance and insured individuals will be able to obtain the treatment at a discounted rate.

Read the article to learn more about this treatment and comment with your opinion!

US OKs drug for postpartum depression

The US Food and Drug Administration, on Tuesday, approved the first medication designed specifically to treat postpartum depression, an illness that affects about one in nine new American mothers. The Centers for Disease Control and Prevention say 11.5 percent of new mothers suffered from postpartum depression in 2012.

The drug is called brexanolone - the trade name is Zulresso - and was manufactured by Sage Therapeutics. One key advantage is that it works quickly, in two days, whereas traditional anti-depressants can take weeks or months to kick in; however, it needs to be administered intravenously in a hospital over the course of 60 hours because of the risk of fainting that was observed in some women during clinical tests.

The most common secondary effects include drowsiness and dryness of the mouth. The medication is expected to be available in late June in the US. US media say the treatment will cost $34,000 a year for people without health insurance. Insurers get it at a discounted rate. The full rate is without the cost of the hospital stay for administering it. 

"Postpartum depression is a serious condition that, when severe, can be life-threatening. Women may experience thoughts about harming themselves or harming their child," said Tiffany Farchione, acting director of the division of psychiatry products in the FDA's Center for Drug Evaluation and Research."

"This approval marks the first time a drug has been specifically approved to treat postpartum depression, providing an important new treatment option," she added.

 

avatar Lee__R

Author: Lee__R, Community Manager

Lee is a Juris Doctor and Doctor of Physical Therapy. Now the Community Manager of Carenity US, he strongly believes that the platform has to be a haven and a tool for patients seeking information, advice or just a friendly encounter.

Comments

on 4/18/19

Hello ladies... Perhaps some of you have dealt with postpartum depression or know someone who has or is diagnosed with postpartum depression and, therefore, may find this article about the first-ever approved drug specifically for postpartum depression.

Feel free to comment and share your thoughts as well.

@Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍  @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ @Hidden username‍ 

on 4/18/19

I think this is great for women who are dealing with this. I had a friend who struggled with this and actually went somewhere for a few months to get better - it was some facility that specialized in it. So whatever can help.

You will also like

Telling someone who is depressed

Depression

Telling someone who is depressed "just snap out of it" or "it could be worse" is not helpful

Read the article
Are you interested in CBD oil to help manage your chronic condition?

Arthritis
Back pain
Chronic anxiety - Stress
Chronic pain
Complex regional pain syndrome
Depression
Dysmenorrhea
Epilepsy
Generalized anxiety disorder
Juvenile idiopathic arthritis
Multiple sclerosis
Myofascial pain
Neuropathic pain
Oligoarticular juvenile arthritis
Osteoarthritis
Patellofemoral syndrome
Pelvi-perineal pains
Post-vasectomy pain syndrome
Postpartum depression
Psoriatic arthritis
Reactive arthritis
Rheumatoid arthritis
Scapulohumeral periarthritis
Schizoaffective disorder
Schizophrenia
Schizotypal personality disorder
Social anxiety disorder
Temporal Lobe Epilepsy

Are you interested in CBD oil to help manage your chronic condition?

Read the article
Physical therapy, chronic pain and chronic diseases: our expert’s answers

Physical therapy, chronic pain and chronic diseases: our expert’s answers

Read the article
Studies, scientific publications, and innovative projects: Carenity is committed to advocating for patients

Studies, scientific publications, and innovative projects: Carenity is committed to advocating for patients

Read the article